Targeting p96^{<i>ABL/BCR</i>} in Ph⁺ ALL cells.

Abstract

<p>(A) SupB15 and K562 cells were lentivirally transduced with shRNA against p96^{<i>ABL/BCR</i>} (siR961 and siR962) and a control shRNA (NTC). The expression of p96^{<i>ABL/BCR</i>} and/or BCR was detected by immunoblotting using anti-BCR antibody. Tubulin was used as loading control. Proliferation was measured using XTT-assay after 3 days. One representative experiment in triplicates ± SD of at least three yielding similar results is given; (B) The effect of targeting p96^{<i>ABL/BCR</i>} by shRNA in SupB15 on STAT5 and ERK1/2 pathway was detected using the indicated antibodies; (C) Down-regulation of p96^{<i>ABL/BCR</i>} in Ph⁺ ALL PD-LTCs by shRNA. Ph⁺ ALL PD-LTCs—PH: fully TKI-responsive; BV: TKI-resistant; as controls were used: HP (Ph^- ALL patient) and VG: t(12;9)-TEL/ABL-positive ALL. The effect of shRNAs on the expression of p96^{<i>ABL/BCR</i>} was tested by immunoblotting using the indicated antibodies and by q-RT-PCR for PH and BV. The Ct values were normalized to that of GAPDH and results are represented as 2^-ΔΔCt. Proliferation was measured by XTT-assay. The mean of at least experiments is given ± SD.</p